drug · small molecule
alisertib
Phase 2updated 3mo agoby $PBYI PUMA BIOTECHNOLOGY, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 19 investigational indications.
targets
Aurora kinase A
all catalysts(0)
nothing on the calendar yet
Trials studying alisertib
- phase1Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
- phase2A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- phase2Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
- phase2A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
- phase2A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- phase2Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
- phase1Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
- phase2Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed just now
Found something off?
comments(0)
5-min edit window · permanent after that